Jennison Associates
NVS icon

Jennison Associates’s Novartis NVS Stock Holding History

Jennison Associates’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-215,883
Closed -$17.8M – 680
2020
Q1 		$17.8M Sell
215,883
-2,626,060
-92% -$234M 0.02% 272
2019
Q4 		$269M Buy
2,841,943
+2,516,662
+774% +$226M 0.27% 56
2019
Q3 		$28.3M Buy
+325,281
New +$29.2M 0.03% 269
2016
Q1 		– Sell
-295,929
Closed -$22.8M – 649
2015
Q4 		$22.8M Sell
295,929
-277,739
-48% -$22.1M 0.02% 406
2015
Q3 		$47.3M Sell
573,668
-294,168
-34% -$26.2M 0.05% 308
2015
Q2 		$76.5M Buy
867,836
+4,899
+0.6% +$449K 0.07% 254
2015
Q1 		$76.2M Buy
+862,937
New +$76.5M 0.07% 255

Other funds holding NVS

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Jennison Associates's NVS Position: Q2 2020 in Review

Jennison Associates sold out of Novartis (NVS) in Q2 2020, closing a stake of 215,883 shares — an estimated $17.8M sold.

Jennison Associates first reported a position in NVS in Q1 2015 and held it in 7 quarters. The position peaked at $269M in Q4 2019. 1,128 funds tracked by Wall St. Rank hold NVS as of Q2 2020.

  • Jennison Associates reported no remaining Novartis position as of Q2 2020 after selling out during the quarter.
  • Jennison Associates sold 215,883 Novartis shares in Q2 2020, an estimated $17.8M.
  • Jennison Associates first reported a position in Novartis in Q1 2015 and held it in 7 quarters.
  • Jennison Associates's Novartis position peaked at $269M in Q4 2019.
  • 1,128 funds tracked by Wall St. Rank held Novartis as of Q2 2020.

Based on Jennison Associates's 13F filing for Q2 2020, filed 6 Aug 2020.